How to invest $10,000 in ASX 200 shares today

Find out why I think CSL Limited (ASX: CSL) and one other ASX 200 share could be a great way to invest $10,000 in the current market.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX 200 shares have had a rocky start to the year. The S&P/ASX 200 Index (ASX: XJO) is down 16.17% in 2020 with the coronavirus pandemic and an oil price war hitting share prices hard.

However, we could be at a turning point in global markets. OPEC+ have slashed their daily oil production by around 10%, while US markets stormed higher overnight on the back of optimism surrounding a possible conronavirus vaccine.

So, what's a good way to invest some spare cash in the market right now?

How to invest $10,000 in ASX 200 shares today

I think it's important to invest in high-quality companies for the long-term. However, I get that it's not easy to just ignore all the short-term share price movements in the meantime. 

I believe CSL Limited (ASX: CSL) could be a smart, long-term choice for investing $10,000 today. It's the largest ASX 200 share by market capitalisation and is worth $139 billion right now. The biotech giant is looking to develop a potentially lifesaving plasma-derived treatment for people with COVID-19. Other than these short-term efforts, I also think CSL has a great business model overall.

It's a leader in blood plasma treatment and biotechnology with a strong business moat. The CSL share price is trading at over $300 per share which is a testament to its long-term success since listing in 1994 at a stock-split-adjusted $0.766 per share. It's hard to bet against the ASX 200 healthcare share given its track record and strong research and development pipeline.

CSL aside, I also like another Aussie large-cap share right now. Commonwealth Bank of Australia (ASX: CBA) shares have crashed lower in 2020 with investors selling off ASX bank shares in droves. 

The CBA share price is down 24.97% since the start of the year thanks to the COVID-19 shutdown. There are fears for what the economic impact of the pandemic will be for Aussie businesses and their lenders. We've seen ASX 200 bank shares fall after announcing billions of dollars of impairments this year despite unprecedented government stimulus measures.

However, I think the CBA share price could be another way to successfully invest $10,000 today. The bank is a key pillar of the Aussie economy and could emerge with a refined business model and strong risk measures. This means CBA could be a leaner, stronger ASX 200 bank share that can churn out consistent profits in the decades ahead.

Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two women look happily at an X-ray of a person's chest with one giving the thumbs up sign.
Healthcare Shares

Up 23% this year, why Ramsay Health Care shares are tipped for more 'compelling upside'

A leading fund manager forecasts more outperformance from Ramsay Health Care’s rebounding share price.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

This ASX 200 stock has soared 1,800%. Is there more to come?

A new approval has this ASX 200 healthcare stock climbing again.

Read more »

Stressed, unhappy, and tired scientist with a headache working on a computer in a lab.
Healthcare Shares

Once untouchable, now unloved: What's up with CSL shares?

CSL's stunning fall has investors questioning its comeback prospects.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

Pro Medicus just struck a revolutionary AI cardiology deal. Here's why that matters

This small-ticket transaction matters far more than its size suggests.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

A deal with Pro Medicus has turned this ASX biotech into a 10-bagger, up more than 30% today

This deal could open up the lucrative US market.

Read more »

Group of doctors celebrate by pumping fists in the air.
Healthcare Shares

Ramsay Health Care shares rebound 15% in June: Can they keep going?

Find out what the experts tip for the ASX healthcare shares next.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Healthcare Shares

Pro Medicus shares jump again as AI deal adds fuel to 40% rally

Pro Medicus shares are bouncing back after a tough start to 2026.

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Healthcare Shares

Why this top investor is snapping up millions of Telix shares

The move adds further fuel to the Telix rebound in 2026.

Read more »